ClinicalTrials.gg

RECORDATI GROUP clinical trials

Part of CVC Capital Partners, which holds 46.82% as of 2025-03-18. Source

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 31 studies whose lead sponsor is RECORDATI GROUP or one of 5 companies grouped under it. 5 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 2, 2026.

Our grouping of 6 registry names, not the registry’s. See them and correct one ↓

Compare RECORDATI GROUP with Yuhan and Shenzhen Salubris Pharmaceuticals →

Pipeline: 2 programs

Each counted once: 2 with a study RECORDATI GROUP leads registered in the last two years.

  • Phase 1
  • Phase 4 (approved, new studies)

The 2 programs — sign in to see the list, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of RECORDATI GROUP’s own registered studies; RECORDATI GROUP’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs RECORDATI GROUP’s studies test, most open studies first — 9 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Coming up

2 of RECORDATI GROUP’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. D
  3. J’27
  4. F
  5. M
  6. A
  7. M
  8. 1J
  9. 1J
  10. A
  11. S
  12. O
  13. N

Add all 2 to your calendar (.ics) → With an account.

What changed recently

From the registry's own updates since Oct 18, 2026.

All 31 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now516%Recruiting 4 · Not yet recruiting 1
  • Under way, not recruiting413%
  • Completed1755%
  • Stopped early413%Terminated 3 · Withdrawn 1
  • Status unknown or other13%

Phase

  • Phase 27
  • Phase 36
  • Phase 44
  • Phase 12

Where

  • France17
  • Italy13
  • Spain12
  • United States12
  • Germany11
  • United Kingdom10

Over the years

  1. 10
  2. 11
  3. 12
  4. 13
  5. 14
  6. 15
  7. 16
  8. 17
  9. 18
  10. 19
  11. 420
  12. 21
  13. 22
  14. 23
  15. 24
  16. 25
  17. 126

By the year each study started; 1 started before 2010. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to RECORDATI GROUP.

  • RECORDATI GROUP
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    21 studies
  • Recordati Rare Diseases
    Acquired — became part of RECORDATI GROUP, 2007 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    3 studies →
  • Laboratorios Casen-Fleet S.L.U.
    Acquired — became part of RECORDATI GROUP, Oct 21, 2013 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies →
  • Recordati UK
    Acquired — became part of RECORDATI GROUP, Mar 16, 2022 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies →
  • Casen Recordati S.L.
    Acquired — became part of RECORDATI GROUP, Oct 21, 2013 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies →
  • Laboratoires Bouchara-Recordati
    Acquired
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →

Studies

Recruiting first, then most recently updated. Showing 31 of 31.